SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 40 filers reported holding SOLENO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 137 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 137 | -51.4% | 0.00% | – |
| Q4 2021 | $0 | – | 282 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 282 | -92.7% | 0.00% | – |
| Q2 2021 | $4,000 | -33.3% | 3,883 | -24.0% | 0.00% | – |
| Q1 2021 | $6,000 | -33.3% | 5,112 | +5.0% | 0.00% | – |
| Q4 2020 | $9,000 | – | 4,870 | +8443.9% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 57 | -89.3% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 535 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | +100.0% | 535 | -5.8% | 0.00% | – |
| Q3 2019 | $1,000 | – | 568 | +3241.2% | 0.00% | – |
| Q2 2019 | $0 | – | 17 | -19.0% | 0.00% | – |
| Q1 2019 | $0 | – | 21 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 21 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 21 | +2000.0% | 0.00% | – |
| Q2 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 10,302,602 | $22,769,000 | 6.37% |
| CVI Holdings, LLC | 1,550,960 | $3,443,000 | 1.28% |
| ORACLE INVESTMENT MANAGEMENT INC | 3,670,384 | $8,148,000 | 1.03% |
| Trellus Management Company, LLC | 366,432 | $813,000 | 0.88% |
| AWM Investment Company, Inc. | 1,550,000 | $3,441,000 | 0.60% |
| Samsara BioCapital, LLC | 750,000 | $1,665,000 | 0.54% |
| Nantahala Capital Management | 7,426,368 | $16,487,000 | 0.50% |
| Consonance Capital Management LP | 3,040,000 | $6,749,000 | 0.40% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,233,676 | $2,739,000 | 0.26% |
| Granite Point Capital Management, L.P. | 2,200,000 | $4,884,000 | 0.25% |